Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

DHT stops hair regrowth in mice, similar to human hair loss.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Parathyroid hormone-related protein helps control hair growth phases in mice.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Estrogen affects how vitamin A is processed in mouse skin, which may impact acne treatment, hair growth, and skin defense.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Finasteride reduces movement issues in Parkinson's disease rats.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.